Rh2 synergistically enhances paclitaxel or mitoxantrone in prostate cancer models

Author(s): Xie X, Eberding A, Madera C, Fazli L, Jia W, et al.


Purpose: We explored the efficacy of the ginsenoside Rh2 and examined its impact on the effective dose of paclitaxel and mitoxantrone in the LNCaP prostate tumor model.

Materials and methods: Cultured LNCaP cell viability was assessed following treatment (48 hours) with Rh2 (0 to 40 microM) alone or in combination with paclitaxel and mitoxantrone. Synergism or antagonism observed when combining treatment was calculated using CalcuSyn software (Biosoft). In addition, the inhibition of LNCaP human xenograft tumor growth was examined in vivo when Rh2 treatment was combined with chemotherapy. Harvested tumors were immunohistochemical stained with p27kip and Ki67.

Results: Rh2 and paclitaxel act synergistically in cultured LNCaP cells to lower ED50 and ED75 values. Rh2 and mitoxantrone are also synergistic. However, when combined as ED95, an antagonistic effect was observed in this cell line. Treatment of LNCaP tumors by Rh2 plus paclitaxel produced a significant decrease in tumor growth and serum prostate specific antigen. Immunohistochemical analysis revealed an apparent but nonsignificant effect on proliferation markers in LNCaP tumors. When Rh2 and mitoxantrone were combined in vivo, there was no significant benefit observed.

Conclusions: These results indicate that the combination of Rh2 and paclitaxel has an effect on growth inhibition that is greater and synergistic, as demonstrated in a cultured LNCaP cell line. Conversely combining Rh2 with mitoxantrone appears to elicit no benefit. Therefore, combination therapy using chemotherapy and Rh2 requires further investigation.

Similar Articles

Interactions between traditional Chinese medicines and Western therapeutics

Author(s): Chan E, Tan M, Xin J, Sudarsanam S, Johnson DE

The Role of Coenzyme Q10 in Heart Failure

Author(s): Weant KA, Smith KM

The impact of coenzyme Q10 on systolic function in patients with chronic heart failure

Author(s): Sander S, Coleman CI, Patel AA, Kluger J, White CM

Studies on the constituents of Japanese and Chinese crude drugs

Author(s): Shibata S, Fujita M, Itokawa H, Tanaka O, Ishii T

Estrogen-like activity of ginsenoside Rg1 derived from Panax notoginseng

Author(s): Chan RY, Chen WF, Dong A, Guo D, Wong MS

[Chemical studies of crude drugs (1)

Author(s): Kitagawa I, Yoshikawa M, Yoshihara M, Hayashi T, Taniyama T

Apoptotic effects of ginsenoside Rh2 on human malignant melanoma A375-S2 cells

Author(s): Fei XF, Wang BX, Tashiro S, Li TJ, Ma JS, et al.

Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells

Author(s): Kim HS, Lee EH, Ko SR, Choi KJ, Park JH, et al.

Liquid chromatographic determination of less polar ginsenosides in processed ginseng

Author(s): Kwon SW, Han SB, Park IH, Kim JM, Park MK, et al.

[Determination of ginsenoside Rd and its metabolites in rat urine by LC-MS]

Author(s): Yang L, Xu SJ, Zeng X, Liu YM, Deng SG, et al.

Determination of Ginsenoside Rh2 in Enzyme Conversion by HPLC

Author(s): Jiang L, Zhao S, Ya L, Li J